about
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized InflammationVasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and InterventionsBreaking boundaries-coagulation and fibrinolysis at the neurovascular interfaceAngiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.Frizzled Receptors in Development and DiseaseFluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and rolesThe molecular constituents of the blood-brain barrierSustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdownBrain Vascular Imaging TechniquesDevelopment and Function of the Blood-Brain Barrier in the Context of Metabolic Control.Kv1.3 channel blocker (ImKTx88) maintains blood-brain barrier in experimental autoimmune encephalomyelitis.Angiopoietin-1 Regulates Brain Endothelial Permeability through PTPN-2 Mediated Tyrosine Dephosphorylation of OccludinEndothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke.Establishment and Dysfunction of the Blood-Brain Barrier.Macrophages treated with particulate matter PM2.5 induce selective neurotoxicity through glutaminase-mediated glutamate generation.A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrierAntiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation.Permeability across a novel microfluidic blood-tumor barrier model.Direct electric stimulation to increase cerebrovascular function.Glial regulation of the blood-brain barrier in health and disease.Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.Dynamic interactions of Plasmodium spp. with vascular endothelium.Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery.The blood-brain barrier in Alzheimer's disease.Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications.Infectious immunity in the central nervous system and brain function.Mechanisms of neuronal migration in the adult brain.Connexin Channels at the Glio-Vascular Interface: Gatekeepers of the Brain.Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system.Structural Elucidation of the Cell-Penetrating Penetratin Peptide in Model Membranes at the Atomic Level: Probing Hydrophobic Interactions in the Blood-Brain BarrierCD146 coordinates brain endothelial cell-pericyte communication for blood-brain barrier development.Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol.YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation.The Wnt Inhibitor Apcdd1 Coordinates Vascular Remodeling and Barrier Maturation of Retinal Blood Vessels.Blood purine measurements as a rapid real-time indicator of reversible brain ischaemia.False friends: Phagocytes as Trojan horses in microbial brain infections.Engineering the human blood-brain barrier in vitro.Lanthanum chloride reduces lactate production in primary culture rat cortical astrocytes and suppresses primary co-culture rat cortical astrocyte-neuron lactate transport.
P2860
Q26770852-8F3D6423-DFC7-4F11-9DD3-6BD96A15D731Q26781557-9FF8E809-5785-4492-84D2-032357DF6761Q26781646-88FB8149-F69D-455A-977D-449C7EDCEB20Q27322343-17BC6522-718E-4BD2-990D-65659C0E53AFQ28071320-37BAA02B-6850-4048-99FF-CDFCFC5DC496Q28074564-B5900A72-FC92-4C0C-A20A-D9D601707196Q28087222-B6C3A861-18F8-4C79-9069-223F11298565Q28817495-7A7279F5-AF4F-4902-B0EF-C75542499C24Q30363574-64B5852F-402F-424A-8E13-CF095E617F42Q33586092-9B218045-5C7F-4232-BFCD-5E66C208B299Q33776820-FE822913-8615-4C41-AE11-2A46B728055CQ35668323-785D2245-EFD9-44B1-886A-04180904F9A8Q35961406-1A3BBD19-56E7-44A9-9730-952406EEFF31Q36306827-FCFD7C45-914B-4F90-888F-9E3D9782847AQ36452166-FBB96341-6173-4F8B-819B-9B28C3CB8903Q36867354-520D18A8-616E-4E64-B3DE-6792D46664E5Q37529187-AB2F1B59-76F4-4F2D-A27E-37EAFEDCDD2AQ37577170-269473F6-567C-4D0A-AE6B-CA2B617C6D2FQ37602559-A4C69FA6-3471-4353-8E9B-E0BDFBB5442DQ38390747-A0F87BAA-540C-4892-A3EC-725784C89623Q38561270-CE64B15C-7A81-449C-B574-57A3CC2B1CF4Q38603996-759DE3C6-FF9F-43B6-ADCB-B760E3739FFBQ38689845-DE9B692B-958A-4E73-9906-2A93E22D7923Q38836486-6841371D-9E4A-4FD4-BEB2-D7BDBF43790CQ38899745-5131EF86-E53A-4B7B-A824-CDC9A6C323EFQ39086482-3FCDAF7C-12A2-4E7A-8BC0-5F37D7CE9727Q39090558-2944FDAE-BE25-4917-ABCC-F1F062966779Q39157722-492BCB38-A421-4698-9019-06028DD22BB6Q39387318-C6E5342E-8220-4806-8B4D-72A14B347293Q39447825-AA158882-0B07-4C82-B23C-DBC36CF9D9EBQ39483024-0561540B-0B8A-4E48-9847-C8840969E168Q41267118-B63C6D18-D261-4602-BB8F-8F770FC758BAQ41660607-D7F8B503-9369-454D-9EB2-D344FB7A38F8Q42516186-4CCA7E4E-4A34-4754-A6C4-39183806A758Q43007023-E9DCFE60-17B5-461C-8694-F186D1574C03Q46712895-5C001F93-BC08-4421-A1CD-570AA517BA5CQ47105207-0853EEE4-5C29-4C2F-98BF-CD54FFBD7561Q47138919-0E150592-AEED-4F32-B090-EE7B6CD630A6Q47163222-A6C649B9-601E-4FA7-BB4B-2BAC67AEC453Q47267719-9D13DDB5-6A21-4DA2-A636-FAB16FA8DDE4
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The blood-brain barrier.
@ast
The blood-brain barrier.
@en
The blood-brain barrier.
@nl
type
label
The blood-brain barrier.
@ast
The blood-brain barrier.
@en
The blood-brain barrier.
@nl
prefLabel
The blood-brain barrier.
@ast
The blood-brain barrier.
@en
The blood-brain barrier.
@nl
P2860
P1476
The blood-brain barrier.
@en
P2093
Alexandre Prat
Richard Daneman
P2860
P304
P356
10.1101/CSHPERSPECT.A020412
P577
2015-01-05T00:00:00Z